Enuzovimab Biosimilar - Research Grade

Human

SARS-CoV-2

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2799

Blue ice

The SARS-CoV-2 spike protein governs host-cell entry and is the focal antigen in coronavirus neutralisation and vaccine research. This recombinant anti-SARS-CoV-2 monoclonal is an unconjugated, non-therapeutic analog of enuzovimab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is produced in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Applications include functional assays, neutralisation and spike-binding studies, reproducible controls, and in vivo models of coronavirus infection, providing the consistency required for large neutralisation and binding research campaigns.

Detects human SARS-CoV-2

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks